Work

Activity of Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) in 22 Patients with Relapsed and Refractory Mantle Cell Lymphoma (MCL).

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.2452.2452

Authors: Anas Younes, Barbara Pro, Maria A. Rodriguez, Jorge E. Romaguera, Peter McLaughlin, Michael Wang, Fredrick B. Hagemeister, Nam H. Dang, Sattva Neelapu, Donald Podoloff

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979609404

FWCI: 2.662

Cites:

Cited by: 17

Related to: 10